- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.07. | Cuprina Holdings LTD - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 24.06. | Morning Market Movers: Cuprina Holdings, CEA Industries, Absci, The Wendy's Company See Big Swings | 733 | AFX News | MEMPHIS (dpa-AFX) - At 7:10 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 16.06. | Cuprina Holdings Falls 22% After 112% Rally - Here's Why CUPR Stock Is Trending | 4 | Benzinga.com | ||
| 15.06. | Cuprina erhält FDA-Zulassung für Produkt zur Madentherapie | 7 | Investing.com Deutsch | ||
| 15.06. | Cuprina receives FDA clearance for maggot wound therapy product | 1 | Investing.com | ||
| 15.06. | Cuprina Holdings (Cayman) LTD: Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots - the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product | 329 | GlobeNewswire (Europe) | SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("CUPR" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| CUPRINA HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 12.06. | Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements | 407 | GlobeNewswire (Europe) | SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | Cuprina requests Nasdaq hearing after delisting notice | 2 | Investing.com | ||
| 29.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing | 193 | GlobeNewswire (Europe) | SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings Cayman Limited Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 22.05. | Cuprina to implement 1-for-8 share consolidation to address Nasdaq compliance | 1 | Seeking Alpha | ||
| 22.05. | Cuprina plant Aktienzusammenlegung im Verhältnis 1:8 zur Sicherung der NASDAQ-Notierung | 5 | Investing.com Deutsch | ||
| 22.05. | Cuprina plans 1-for-8 reverse stock split to meet Nasdaq rules | 1 | Investing.com | ||
| 22.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings announces 1-for-8 Share Consolidation | 380 | GlobeNewswire (Europe) | SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 14.05. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.04. | Cuprina Holdings LTD - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 21.04. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.03. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board | 773 | GlobeNewswire (Europe) | SINGAPORE, March 11, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic... ► Artikel lesen | |
| 11.03. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 09.12.25 | Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth | 397 | GlobeNewswire (Europe) | SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CO-DIAGNOSTICS | 2,565 | -0,19 % | Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test | More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 27 individual studies and over 10,000 PCR test cup runs
Analytical... ► Artikel lesen | |
| CYTOSORBENTS | 0,356 | +2,89 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,180 | -0,95 % | Clover Health Investments, Corp.: Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026 | ||
| FULGENT GENETICS | 17,800 | 0,00 % | Fulgent reports interim data for cancer drug FID-007 trial | ||
| EMBECTA | 2,683 | -1,00 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| CHECK-CAP | 1,050 | +7,14 % | Humanoid Global meldet Fortschritte von MBody AI bei der kommerziellen Expansion und dem geplanten Unternehmenszusammenschluss mit Check-Cap | Vancouver, BC / 14. Juli 2026 / IRW-Press / Humanoid Global
Holdings Corp. ("Humanoid Global" oder das "Unternehmen")
(CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), ein börsennotierter
Investment-Emittent... ► Artikel lesen | |
| MEDLINE | 33,000 | -2,94 % | Medline COO Stephen Miller to retire | ||
| ELECTROCORE | 5,150 | -6,36 % | electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes | Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness... ► Artikel lesen | |
| CATHETER PRECISION | 0,611 | +0,30 % | Catheter Precision Plunges as Traders Unwind Gains from Recent News | ||
| CLEARPOINT NEURO | 15,960 | 0,00 % | EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery | ||
| ENVUE MEDICAL | 0,470 | +1,53 % | ENvue Medical, Inc. - 8-K, Current Report | ||
| FIREFLY NEUROSCIENCE | 1,120 | 0,00 % | Firefly Neuroscience, Inc.: Firefly Confirms Public-Private Partnership with the Department of War | Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service Members Partnership Represents a Significant Expansion of... ► Artikel lesen | |
| OMADA HEALTH | 20,600 | 0,00 % | Omada Health, Inc.: Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support | SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program. Omada... ► Artikel lesen | |
| ENDRA LIFE SCIENCES | 5,450 | -1,62 % | ENDRA Life Sciences Inc. - 8-K, Current Report | ||
| FEMASYS | 3,630 | +0,83 % | Femasys Inc.: Femasys Regains Compliance with Nasdaq Listing Requirements | ATLANTA, June 24, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective... ► Artikel lesen |
CUPRINA HOLDINGS CAYMAN LIMITED gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 4,180 Euro und damit +2,20 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CUPRINA HOLDINGS CAYMAN LIMITED finden Sie auf Wallstreet Online.